Furthermore, germline mutations in CDH1 lead to a 67–83% lifetime risk of developing diffuse type GC, and an increased risk of developing lobular subtype breast cancer, which is strongly associated with PM formation as well (Pharoah et al, 2001; Inoue et al, 2017). The gene discussed is CDH1; the disease is gastric cancer.